← Back to trialsNCT02361320
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2015-03-09Est. Completion: 2028-06-27
Enrollment target: 259 participants Locations- M D Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid TumorUrinary Bladder NeoplasmTriple Negative Breast CancerNon-small Cell Lung CancerEsophageal CancerPancreatic CancerOvarian CancerCervical CancerHead and Neck Squamous Cell CarcinomaProstate CancerRenal Pelvis CancerBladder Cancer
The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in particip…
Duarte, United StatesEst. completion May 2027
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer | MicrobiomeTrialsPancreas CancerOligometastatic
The EXPAND trial (EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease) is a randomized …
Camden, United StatesEst. completion Jun 29, 2029
Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design…
Los Angeles, United StatesEst. completion Jun 2028